29 results match your criteria: "Kerckhoff-Heart-Centre[Affiliation]"

Native T1 adds independent value for cardiovascular risk assessment beyond global longitudinal strain in an all-comers real-world clinical patient population.

Eur Heart J Open

September 2025

Department of Cardiology, Campus Kerckhoff of the Justus-Liebig-University Giessen, Kerckhoff-Heart-Centre, Kerckhoff-Clinic, Benekestr. 2-8, 61231 Bad Nauheim, Germany.

Aims: Deformation imaging remains underused for cardiovascular risk assessment. As tissue characterization has now been recognized as an additional assessment tool, we sought to investigate the significance of native T1 and extracellular volume (ECV) in an unselected clinical routine population.

Methods And Results: The single-centre, prospective cardiovascular magnetic resonance (CMR) registry included patients referred for clinical CMR.

View Article and Find Full Text PDF

Background: Combining pretest probability (PTP) with computed tomography angiography (CTA) for diagnosing obstructive coronary artery disease (CAD) has not yet been determined.

Objectives: The purpose of this study was to evaluate the accuracy of PTP calculation alone and with CTA for diagnosing CAD.

Methods: A total of 65 prospective diagnostic accuracy studies of patients clinically referred to invasive coronary angiography with stable chest pain were included in this international collaborative individual patient data Collaborative Meta-Analysis of Cardiac CT (COME-CCT) meta-analysis.

View Article and Find Full Text PDF

Predictors of symptom improvement in patients with chronic coronary syndrome after percutaneous coronary intervention.

Clin Res Cardiol

December 2024

University Heart Centre Regensburg, Department of Internal Medicine II, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.

Article Synopsis
  • Decreases in symptom severity and enhancements in quality of life are key objectives for treating patients with symptomatic chronic coronary syndrome (CCS) using invasive methods like PCI (Percutaneous Coronary Intervention).
  • A study involving 145 patients showed significant improvements in quality of life, physical limitation, and angina frequency six months post-PCI, with the most significant improvements seen in those with worse baseline health status.
  • Engaging in physical activity after the procedure further boosted quality of life improvements, indicating that patient health before treatment is crucial for outcomes, while demographic factors and psychological traits had minimal impact.
View Article and Find Full Text PDF

Paravalvular leak (PVL) is a shortcoming that can erode the clinical benefits of transcatheter valve replacement (TAVR) and therefore a readily applicable method (aortography) to quantitate PVL objectively and accurately in the interventional suite is appealing to all operators. The ratio between the areas of the time-density curves in the aorta and left ventricular outflow tract (LVOT-AR) defines the regurgitation fraction (RF). This technique has been validated in a mock circulation; a single injection in diastole was further tested in porcine and ovine models.

View Article and Find Full Text PDF

Introduction: Isolated redo-mitral valve replacement (iMVR) is underreported and often mixed up with endocarditis in the present literature. The present study compares first with redo iMVR in noninfective mitral disease.

Patients And Methods: A total of 3821 mitral valve procedures were analyzed.

View Article and Find Full Text PDF

Background: Aortic regurgitation (AR) following transcatheter aortic valve replacement (TAVR) is a major predictor of short- and long-term survival. Thus far, no independent quantitative comparison of AR among commercially available transcatheter heart valves (THVs) has been performed.

Objectives: We sought to assess and compare the degree of acute AR following TAVR between 11 commercially available THVs and update our previous multicenter, pooled analysis.

View Article and Find Full Text PDF

First Transfemoral TAV-in-TAV Implantation of an ACURATE Neo2 Into a Degenerated Lotus Prosthesis.

Can J Cardiol

March 2022

Department of Cardiology, Kerckhoff Heart Centre, Bad Nauheim, Germany; German Centre for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Frankfurt am Main, Germany; Department of Cardiology, Justus-Liebig University of Giessen, Giessen, Germany.

View Article and Find Full Text PDF

Introduction: Sex disparities exist in coronary artery disease (CAD) in terms of risk profile, clinical management and outcome. It is unclear if differences are also present in coronary aneurysms, a rare variant of CAD.

Methods: Patients were selected from the international Coronary Artery Aneurysm Registry (CAAR; ClinicalTrials.

View Article and Find Full Text PDF

Background: Transcatheter aortic valve implantation (TAVI) has become standard treatment for elderly patients with symptomatic severe aortic valve stenosis. The ACURATE neo AS study evaluates 30-day and 1-year clinical and hemodynamic outcomes in patients treated with the ACURATE neo2 valve.

Methods: The primary endpoint of this single-arm multicenter study is 30-day all-cause mortality.

View Article and Find Full Text PDF

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of patients with severe aortic stenosis and is now standard of care for high surgical risk patients and a valid alternative strategy in intermediate risk patients. Recently, TAVR has shown excellent results in low-risk patients, indicating an imminent extension toward this population. Improvements in procedural outcomes are the result of increasing operator experience, sophisticated imaging for procedural planning but also due to the continuous evolution of transcatheter heart valves developed to minimize procedural complications.

View Article and Find Full Text PDF

Objective: To determine whether coronary computed tomography angiography (CTA) should be performed in patients with any clinical probability of coronary artery disease (CAD), and whether the diagnostic performance differs between subgroups of patients.

Design: Prospectively designed meta-analysis of individual patient data from prospective diagnostic accuracy studies.

Data Sources: Medline, Embase, and Web of Science for published studies.

View Article and Find Full Text PDF

Clinical experience with contact-force and flexible-tip ablation catheter designs.

J Interv Card Electrophysiol

October 2016

Electrophysiology Department, Kerckhoff Heart Centre, Benekestr. 2-6, 61231, Bad Nauheim, Germany.

Purpose: Lesion formation is a critical determinant of technical and clinical success of pulmonary vein isolation. Different catheter designs aim to enhance tissue contact during ablation to enable optimized lesion formation. We analyzed procedural characteristics and predictors of clinical success in patients ablated with three different contemporary ablation catheters.

View Article and Find Full Text PDF

Pacemaker technologies have advanced dramatically over the decades since they were first introduced, and every year many thousands of new implants are performed worldwide. However, there continues to be a high incidence of acute and chronic complications, most of which are linked to the lead or the surgical pocket created to hold the device. A leadless pacemaker offers the possibility of bypassing these complications, but requires a catheter-based delivery system and a means of retrieval at the end of the device's life, as well as a way of repositioning to achieve satisfactory pacing thresholds and R waves, a communication system and low peak energy requirements.

View Article and Find Full Text PDF

Background: Radiofrequency (RF) current is used as a common energy source to perform pulmonary vein isolation (PVI) in patients with atrial fibrillation. We applied measurements of the blood concentration of cTnI as a surrogate parameter for the injured cell mass.

Aim: To clarify which parameters are major determinants of myocardial injury, estimated by cTnI, after PVI with RF ablation.

View Article and Find Full Text PDF

Aortic valve replacement (AVR) is a routine procedure for decades to treat patients with symptomatic aortic stenosis. The introduction of transcatheter aortic valve implantation (TAVI) by Professor Alain Cribier has paved the way for minimally invasive therapeutic options for elderly and high-risk patients with aortic stenosis. Transfemoral and transapical aortic valve implantations have become routine procedures in many centres around Europe.

View Article and Find Full Text PDF

Background: The goal of this study was to analyze impact of metabolic syndrome (MetS) and impaired renal function on long-term follow-up after catheter ablation of atrial fibrillation (AF).

Methods And Results: A total of 702 consecutive patients with AF (age = 58 year, history of AF = 5 year, male = 478, paroxysmal atrial fibrillation = 416, coronary artery disease = 62, hypertension = 487) considered for catheter ablation were enrolled in the study. The MetS was diagnosed at admission in 276 patients.

View Article and Find Full Text PDF

Background: Many studies have used creatinine kinase (CK), myocardial bound for CK (CK-MB), and cardiac troponin I (cTnI) and T (cTnT) to evaluate myocardial cells injury after ablation. We applied measurements of the blood concentration of cardio-specific biomarkers as surrogates for the injured cell mass.

Aim: To clarify which of the standard biomarkers are useful in the evaluation and quantification of lesions produced by cryoballoon ablation (CBA) during pulmonary vein isolation.

View Article and Find Full Text PDF

Background: Dual-source CT (DSCT) promises a significant reduction of radiation dose exposure for coronary CT angiography (CTA). Large studies on radiation dose estimates are rare.

Objective: To compare radiation dose estimates of DSCT with 16- and 64-slice multidetector CT (MDCT) for non-invasive coronary angiography.

View Article and Find Full Text PDF
Article Synopsis
  • Dual-source computed tomography (DSCT) is effective in detecting coronary artery stenoses, even without heart rate control in patients with a high likelihood of coronary artery disease (CAD).
  • In a study involving 76 patients, DSCT achieved a high accuracy rate in identifying significant coronary stenoses when compared to the standard of quantitative coronary angiography (QCA).
  • The results demonstrated impressive sensitivity and specificity, indicating that DSCT can reliably diagnose coronary artery issues, even at higher heart rates.
View Article and Find Full Text PDF

2-Deoxy-D-glucose (2-DG) is a glucose analogue that has been proposed for cancer therapy due to its cytostatic properties. Its effect on the proliferation of smooth muscle cells and endothelial cells has not been fully clarified. The aims of this study were to investigate the effects of 2-DG on the proliferation of porcine aortic endothelial cells (PAEC) and porcine smooth muscle cells (PSMC), to establish an overview of its dose-dependent inhibitory capacity and to examine whether the short-term incubation of cells with 2-DG has an impact on cell proliferation in culture.

View Article and Find Full Text PDF

Rapamycin is an increasingly important immunosuppressive drug and reduces restenosis after coronary stenting, but its effects on cardiac contractility are largely unknown. We investigated the acute inotropic effects of rapamycin on isolated human cardiomyocytes. Cardiomyocytes were enzymatically isolated from right atrial appendages obtained during routine coronary artery bypass surgery.

View Article and Find Full Text PDF

Aims: Drug-eluting stents have been reported to effectively reduce in-stent restenosis (ISR). However, the effectiveness and safety have yet been investigated only in small trials or case series. The aim of this prospective large scale registry was to show that treatment of ISR with sirolimus eluting stents (SES) is safe, effective and feasible in daily routine.

View Article and Find Full Text PDF